Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 14984018)

Published in Diabetes Obes Metab on November 01, 2003

Authors

Andrew J Krentz1

Author Affiliations

1: Southampton General Hospital, Southampton, UK. a.j.krentz@soton.ac.uk

Articles citing this

Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst (2009) 1.52

Berries: emerging impact on cardiovascular health. Nutr Rev (2010) 1.21

Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men. BJU Int (2007) 1.07

Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord (2013) 1.06

Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes (2014) 1.05

Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function. PLoS One (2011) 1.02

Treatment of dyslipidemia in patients with type 2 diabetes. Lipids Health Dis (2010) 0.95

Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study. Cardiovasc Diabetol (2005) 0.95

The antihyperlipidemic activities of 4(3H) quinazolinone and two halogenated derivatives in rats. Lipids Health Dis (2005) 0.92

Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans. Ann Med (2012) 0.87

Effects of atorvastatin and rosuvastatin on high-sensitivity C-reactive protein and lipid profile in obese type 2 diabetes mellitus patients. J Pharmacol Pharmacother (2011) 0.85

Male gender, increased blood viscosity, body mass index and triglyceride levels are independently associated with systemic relative hypertension in sickle cell anemia. PLoS One (2013) 0.85

Paederia foetida Linn. leaf extract: an antihyperlipidemic, antihyperglycaemic and antioxidant activity. BMC Complement Altern Med (2014) 0.85

Favorable impact of Nigella sativa seeds on lipid profile in type 2 diabetic patients. J Family Community Med (2012) 0.82

Effect of concomitant administration of L-glutamine and cycloart-23-ene-3β, 25-diol (B2) with sitagliptin in GLP-1 (7-36) amide secretion, biochemical and oxidative stress in streptozotocin - nicotinamide induced diabetic Sprague Dawley rats. PLoS One (2013) 0.80

The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver. Diabetol Metab Syndr (2010) 0.79

Prevalence of Type 2 Diabetes Mellitus among Urban Sikh Population of Amritsar. Indian J Community Med (2016) 0.78

The association between improved quality diabetes indicators, health outcomes and costs: towards constructing a "business case" for quality of diabetes care--a time series study. BMC Endocr Disord (2014) 0.78

Dysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury. Int J Biol Sci (2016) 0.78

Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients. PLoS One (2016) 0.77

Prevalence and comorbidities of known diabetes in northeastern Italy. J Diabetes Investig (2013) 0.77

Role of SN1 lipases on plasma lipids in metabolic syndrome and obesity. Arterioscler Thromb Vasc Biol (2014) 0.76

Suppression of low-density lipoprotein oxidation, vascular smooth muscle cell proliferation and migration by a herbal extract of Radix Astragali, Radix Codonopsis and Cortex Lycii. BMC Complement Altern Med (2011) 0.76

Hypoglycemic and hypolipidemic activities of aqueous extract of flowers from Nycantus arbor-tristis L. in male mice. BMC Complement Altern Med (2015) 0.75

Markers of cardiovascular risk in postmenopausal women with type 2 diabetes are improved by the daily consumption of almonds or sunflower kernels: a feeding study. ISRN Nutr (2012) 0.75

Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (probe) trial. Curr Ther Res Clin Exp (2004) 0.75

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain. BMC Fam Pract (2007) 0.75

p66Shc: A novel biomarker of tubular oxidative injury in patients with diabetic nephropathy. Sci Rep (2016) 0.75

[Diagnosis and prevalence of metabolic syndrome in diabetics followed in a context of limited resources: the case of Burkina Faso]. Pan Afr Med J (2014) 0.75

Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women? Diabetol Metab Syndr (2017) 0.75

Gestational diabetes mellitus is associated with increased leukocyte peroxisome proliferator-activated receptor γ expression. Arch Med Sci (2015) 0.75

Possible inhibition of hydroxy methyl glutaryl CoA reductase activity by nicotinic acid and ergosterol: as targeting for hypocholesterolemic action. Afr Health Sci (2016) 0.75

Modulatory effect of dianthrone rich alcoholic flower extract of Cassia auriculata L. on experimental diabetes. Integr Med Res (2017) 0.75